This study is for pregnant women (ages 18-50) who have gestational diabetes (diabetes that develops during pregnancy) and whose blood sugar isn't controlled with metformin alone, so they need to add insulin. Researchers want to find out if continuing to take metformin when you start insulin, or stopping metformin when you start insulin, is better. You would be randomly assigned to one of two groups: either continuing metformin while also taking insulin, or stopping metformin and only taking insulin. The main goal is to see if continuing metformin reduces the amount of insulin needed. The study aims to enroll 130 participants, but its current recruitment status is unclear.

Study design

This is a randomized study comparing two treatment approaches for gestational diabetes, involving approximately 130 participants.

What's involved

You would need to be willing to take oral medication and adhere to a metformin regimen, and be willing to take insulin if needed. You would be followed from enrollment until delivery, for a maximum of 20 weeks.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed from enrollment into the study until delivery, for a maximum of 20 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.